Bacterial Vaginosis in pregnancy and it's fetomaternal outcome.

Dr. Chintamani Mohanta, Dr. Kumudini Pradhan, Dr.Sudhanshu Sekhar Nath, Dr. Sangram Keshari Sahoo

Abstract


Introduction:The presence of Bacterial Vaginosis (BV)  at a particular gestational age may be a factor in the subsequent development of pregnancy complications and the risk for disease may change based on BV positivity during different stages of gestation. Current study aims to evaluate the prevalence of BV in obstetrics patients using easily available rapid inexpensive diagnostic tests and the detailed fetal effects and maternal effects during pregnancy andpost partum periods.

Aims and Objective: To study the prevalence, risk factors of BV andto evaluate the correlation between BV and adverse maternal and fetal outcome in pregnancy.

Materials and Method: 204 pregnant women attending the gynaecological OPD satisfying inclusion criteria were enrolled for this study, which is done over a period of 2 years (Nov-2013 to Nov-2015) in the Department of Obstetrics and Gynaecology,in collaboration with Department of Microbiology , VSSIMSAR,Burla,Sambalpur.

Results:Prevalence of bacterial Vaginosis in pregnancy  was 22.55% (46cases were Bacterial Vaginosis positive among the study group of 204cases) and more common among the 20-25years of age group ,lower SES(18.62% vs 3.92% in the high socioeconomic category of women) ,rural habitat , education of primary level of women, Hindu religion (60.86%).UnbookedPrimigravida (63.04%) in the 3rd trimester were commonly affected women.

Maternal complications mostly include- Premature Rupture Of Membrane,Pretermlabour,Chorioamnitis  and puerperal sepsis.

Fetal complications include – Birth asphyxia andLow Birth Weight.

Conclusion: BV can be implicated as one of the contributory factors ofadverse maternal and fetal outcome.


Keywords


Bacterial vaginosis, Maternal and fetal complications.

Full Text:

PDF

References


Goldenberg RL, Hauth JC, Andrews WW. Intrauterine infection and preterm delivery. N Engl J Med 2000; 342(20):1500-7.

Bacterial Vaginosis: clinical, epidemiologic and microbiological features, Didier Silveira Castellano Filho*,CláudioGaluppoDiniz**,VâniaLúcia da Silva*(HU Revista, Juiz de Fora, v. 36, n. 3, p. 223-230, jul./set. 2010) andCribby, S.; Taylor, M.; Reid, G. Vaginal microbiota and the use of probiotics. Interdisciplinary Perspective Infectious Disease, New York, v. 08, no. 4, p. 256-64, Nov. 2008.

Bacterial Vaginosis: Literature review of treatment options with specific emphasis on non-antibiotic treatment Ilse Truter* and Michael Graz Department of Pharmacy, Drug Utilization Research Unit (DURU), Nelson Mandela Metropolitan University (NMMU), P. O. Box 77000, Port Elizabeth, 6031, South Africa. And Hillier S, et al. (2008). Bacterial Vaginosis. In KK Holmes et al., eds., Sexually Transmitted Diseases, 4th ed., pp. 737–68. New York: McGraw-Hill.

Amsel R, Totten PA, Spiegel CA, et al. Nonspecific vaginitis. Diagnostic criteria and microbial and epidemiologic associations. Am J Med 1983; 74:14.

Morris M, Nicoll A, Simms I, et al. Bacterial vaginosis: a public health review. BJOG 2001; 108:439.

Klebanoff SJ. Myeloperoxidase-halide-hydrogen peroxide antibacterial system. J Bacteriol. 1968;95:2131–38.

Kenyon S, Boulvain M, Neilson J. Antibiotics for preterm rupture of membranes [Cochrane review]. In: Cochrane Database of Systematic Reviews 2003 Issue 2. Chichester (UK): John Wiley & Sons, Ltd; 2003. DOI: 10.1002/14651858.CD001058

Allsworth JE, Peipert JF. Prevalence of bacterial vaginosis: 2001-2004 National Health and Nutrition Examination Survey data. ObstetGynecol 2007; 109:114

Indu Lata1, Yashodhara Pradeep2, Sujata2, Amita Jain3

Estimation of the incidence of bacterial vaginosis and other vaginal infections and its consequences on maternal/fetal outcome in pregnant women attending an antenatal clinic in a tertiary care hospital in North India, K. G. Medical University, Lucknow, UP, India 2009.

Tânia Maria M. V. da Fonseca et al. “Pathological Vaginal Discharge among Pregnant Women: Pattern of Occurrence and Association in a Population-Based Survey”, Raul Andres Mendoza-Sassi, Jun 05, 2014

Rajshree Seth1, Manju Maheshwari2, Leena Saini3, Vikrant Sharma4 , Effects Of Bacterial Vaginosis On Perinatal Outcome ,2010

Workowski, K. A.; Berman, S. M. Sexually transmitted diseases treatment guidelines, 2006. Morbidity and Mortality Weekly Report. Recommendations and Reports, Atlanta, v. 55, no. RR-11, p. 1-94, Aug. 2006.

Yudin, M. H.; Money, D. M. Screening and management of bacterial vaginosis in pregnancy. Journal of Obstetrics and Gynaecology Canada, Toronto, v. 30, no. 8, p. 702-16, Aug. 2008.

Nugent, R. P.; Krohn, M. A.; Hillier, S. L. Reliability of diagnosing bacterial vaginosis is improved by a standardized method of gram stain interpretation. Journal of Clinical Microbiology, Washington, D. C., v. 29, no. 2, p. 297-301, Feb. 1991.

SHA, B. E. et al. Utility of amsel criteria, nugent score, and quantitative PCR for Gardnerella vaginalis, Mycoplasma hominis, and Lactobacillus spp. for diagnosis of bacterial vaginosis in human immunodeficiency virus-infected women. Journal of Clinical Microbiology, Washington, D. C., v. 43, no. 9, p. 4607-12, Sep. 2005.

Mathew R, Kalyani J, Bibi R, Mallika M. “prevalence of bacterial Vaginosis in antenatal women.” Indian J Patho Microbiol.2001;44:113-6.

Jenifer EAllsworth,PhD and Jeffery F. Peipert,MD,MPH, “Prevalence of Bacterial Vaginosis.”ACOG 2007,114-20.

Goldenberg RL, Klebanoff MA, Nugent R, et al. Bacterial colonization of the vagina during pregnancy in four ethnic groups: vaginal infections and prematurity study group. Am J ObstetGynecol 1996;174:1618–21.

R L Goldenberg, J D Iams, B M Mercer, P J Meis, A H Moawad, R L Copper, A Das, E Thom, F Johnson, D McNellis, M Miodovnik, J P Van Dorsten, S N Caritis, G R Thurnau, and S F Bottoms. The preterm prediction study: the value of new vs standard risk factors in predicting early and all spontaneous preterm births. NICHD MFMU Network. Am J Public Health. 1998 February; 88(2): 233–238

Ferguson SE, Smith GN, Salenieks ME, Windrim R, Walker MC. Premature rupture of the fetal membranes: Nutrutional and Socioeconomic Factors. ObstetGynecol 2002; 100: 1250- 6

Simhan HN, Caritis SN, Krohn MA, Hillier SL. The vaginal inflammatory milieu and the risk of early premature preterm rupture of membranes. Am J Obstet Gynecol. 2005;192(1):213–8.

Nugent, R. P.; Krohn, M. A.; Hillier, S. L. Reliability of diagnosing bacterial vaginosis is improved by a standardized method of gram stain interpretation. Journal of Clinical Microbiology, Washington, D. C., v. 29, no. 2, p. 297-301, Feb. 1991.

Daikoku, NH, Kaltreider, DF, Khouzami, VA et al, Premature rupture of membranes and spontaneous pre-term labour: Maternal endometritis risks. Obstet Gynecol. 1982;59:13–20.

R. L. Naeye and E. C. Peters, “Causes and consequences of premature rupture of fetal membranes,” The Lancet, vol. 1, no. 8161, pp. 192–94, 1980.

Pastor LM, Thorp JM, Jr, Royce RA, Savitz DA, Jackson TP; “Risk score for antenatal bacterial Vaginosis;BV pin points” J perinatol 2002:22:125-32.

Larsson, P.G. et al. Bacterial vaginosis: a disturbed bacterial flora and treatment enigma. APMIS: ActaPathologicaMicrobiologicaetImmunologicaScandinavica, Copenhagen, v. 113, p. 305-16, 2005.

Cook RL, Redondo-Lopez V, Schmitt C et al;”Clinical,microbiological,and biochemical factors in recurrent bacterial Vaginosis.”J ClinMicrobiol;1992;30:870-77.

Khan KJ, Shah R, Gautam M, Patil S (2007). Clue cells. Indian J. Sex. Transm. Dis. 28:108-9.

Chakraborty Tanuja,PatelDisha A, GuptaPraveg A,”J Obstetrics GynecolIndia;vol.58;no.5;sept/oct 2008;page 402-5.

Kenyon S, Boulvain M, Neilson J. Antibiotics for preterm rupture of membranes [Cochrane review]. In: Cochrane Database of Systematic Reviews 2003 Issue 2. Chichester (UK): John Wiley & Sons, Ltd; 2003. DOI: 10.1002/14651858.CD001058.

McGregor JA, French JI, Richter R, Vuchetich M, Bachus V, Seo K, Hillier S, Judson FN, McFee J, Schoonmaker J, et al. Cervicovaginal microflora and pregnancy outcome: results of a double-blind, placebo-controlled trial of erythromycin treatment. Am J Obstet Gynecol. 1990 Nov;163(5 Pt 1):1580–91.

TopioKurki, MD, AullikkiSivonen, MD and OlaviYlikorkola,MD; “Bacterial Vaginosis in early pregnancy and pregnancy outcome”,ObstetGynaecol 1992;80:173-77.

Gravett MG, Nelson HP, DeRouen T, Critchlow C, Eschenbach DA, Holmes KK. Independent associations of bacterial vaginosis and Chlamydia trachomatis infection with adverse pregnancy outcome.JAMA. 1986 Oct 10;256(14):1899–03.

Gravett MG, Hummel et al ,”Preterm labor associated with subclinical amniotic infection and bacterial Vaginosis”:Obst. & Gynaecology 1986:67;229-37.

Mariam Anjum et al; “Study of bacterial Vaginosis in pregnancy in pregnancy and its maternal and fetal outcome.”2011;RGUHS;Karnataka.

Purwar M, UghadeS,Bhagat B, Agarwal V,Kulkarni H, “Bacterial vaginosis in early pregnancy and adverse pregnancy outcome.”JObst. GynaecologyRes 2001;27:175-81.

Laxmi U, Agrawal S, Raghunandan C, Randhawa VS, Saili A (2012). Association of bacterial vaginosis with adverse fetomaternal outcome in women with spontaneous preterm labor: a prospective cohort study. J. Matern. Fetal Neonatal Med. 25(1):64–67.

Jacobssion B, Pemevi P, ChidekelL,Jorgenplatz-ChritensenJ,”Bacterial Vaginosis in early pregnancy may predispose for preterm birth and post partum endometritis.”ActaObstGynecolScand 2002;81:1006-10.

Jacobssion B, Pemevi P, ChidekelL,Jorgenplatz-ChritensenJ,”Bacterial Vaginosis in early pregnancy may predispose for preterm birth and post partum endometritis.”ActaObstGynecolScand 2002;81:1006-10.

Fonseca TMV, César JA, Hackenhaar AA, Ulmi EE, Neumann NA. Corrimento vaginal referido entre gestantesemlocalidadeurbana no sul do Brasil: prevalência e fatoresassociados. Cad SaúdePública. 2008;24(3):558-6

P. Oakeshott, S. Kerry, S. Hay and P. Hay, Bacterial vaginosis and preterm birth: a prospective community-based cohort study, Br J Gen Pract 54 (2004), pp. 119–22.

Donders AR, van der Heijden GJ, Stijnen T, Moons KG. Review: a gentle introduction to imputation of missing values. J Clin Epidemiol.2006;59:1087–91.

Koumans EH, Kendrick JS. Preventing adverse sequelae of bacterial vaginosis: a public health program and research agenda. Sex Transm Dis. May 2001;28(5):292-97.and Hedges SR, Barrientes F, Desmond RA, Schwebke JR. Local and systemic cytokine levels in relation to changes in vaginal flora. J Infect Dis. Feb 15 2006;193(4):556-62.

Henn EW, Kruger TF, Siebert TI (2005).Vaginal discharge reviewed: The adult pre-menopausal female. South Afr.FamPract.47(2):30.


Refbacks

  • There are currently no refbacks.